Success Metrics

Completion Rate
0%(0/8)
Active Trials
0(0%)
Terminated
8(100%)

Phase Distribution

Ph phase_2
1
13%
Ph phase_3
7
88%

Phase Distribution

0

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
7(87.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 8 finished

Non-Completion Rate

100.0%

8 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Terminated(8)

Detailed Status

Terminated8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (12.5%)
Phase 37 (87.5%)

Trials by Status

terminated8100%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

NCT00970424
terminatedphase_3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

NCT01089790
terminatedphase_3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

NCT00947557
terminatedphase_3

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

NCT00998686
terminatedphase_3

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

NCT00850239
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00970424Phase 3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Terminated
NCT01089790Phase 3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone

Terminated
NCT00947557Phase 3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

Terminated
NCT00998686Phase 3

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Terminated
NCT00850239Phase 3

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Terminated
NCT00865592Phase 3

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Terminated
NCT01101945Phase 2

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Terminated
NCT00958269Phase 3

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Terminated

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8